Functional Assessment Scores Not Interchangeable in Adolescents With Juvenile Idiopathic Arthritis
Although there was high agreement and similar classification of change among the questionnaires, these may not be completely interchangeable.
Pediatric Rheumatology
Effect of ABCG2 Variants on Pediatric-Onset Hyperuricemia and Gout
Researchers examined the ABCG2 gene in a hyperuricemia and gout cohort, focusing on patients with pediatric-onset disease.
Juvenile-Onset Mixed Connective Tissue Disease Associated With Systolic Dysfunction
Patients with juvenile mixed connective tissue disease had impaired left and right ventricular function compared with matched controls after a median of 15 years disease duration.
Methotrexate Persistence, Adverse Drug Reactions in Juvenile Idiopathic Arthritis
Data show that more than half of patients with juvenile idiopathic arthritis were no longer on methotrexate therapy.
Patterns of Joint Behavior Useful for Juvenile Arthritis Classification
An algorithm that can classify patients with juvenile idiopathic arthritis (JIA) into seven distinct groups based on patterns of swollen or painful joints in the body can help predict disease course.
Long-Term Outcomes Evaluated in Adult Patients With Juvenile Idiopathic Arthritis
Long-term follow-up data show that many adult patients with JIA have active disease with low remission rates.
Comparing Sensitivities of Childhood-Onset SLE Classification: SLICC vs ACR Criteria
Researchers sought to compare the sensitivities of ACR and SLICC classification criteria in childhood-onset SLE.
Program in Pediatric Rheumatology Clinic Increases Education on Teratogenic Medications
A series of interventions introduced through a quality improvement project can increase the frequency of both teratogen education and urine pregnancy screening in patients taking teratogenic medications for rheumatic disease.
Gut Microbiota Composition Analyzed in Juvenile Idiopathic Arthritis
Patients with juvenile idiopathic arthritis demonstrated evidence of dysbiosis and reduced diversity in the gut microbiome.
TNFi Discontinuation During Early Pregnancy Not Linked With Worse RA, JIA Outcomes
Discontinuing TNFi therapy before 20 weeks gestation was feasible in women with RA and JIA who enter pregnancy with well-controlled disease.
-
Loading...
-
Loading...
Next post in Rheumatoid Arthritis
